We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

ROCHE DIAGNOSTICS CORP

Roche Diagnostics Corporation is the North American headquarters of Roche Diagnostics, a global leader in diagnostics... read more Featured Products: More products

Download Mobile App




Prothrombin Time Derived from POC Test Compared to Laboratory Test

By LabMedica International staff writers
Posted on 17 Feb 2015
Print article
Roche\'s CoaguChek XS system for Prothrombin time/international normalized ratio
The CoaguChek XS system for Prothrombin time/international normalized ratio (Photo courtesy of ROCHE DIAGNOSTICS CORP)
Prothrombin time/international normalized ratio (PT/INR) is used for dosing and monitoring oral anticoagulant therapy (OAT) based on warfarin, as the therapeutic range of warfarin is narrow and there is a considerable variation in inter- and intra-individual pharmacologic response.

One of the most widely used point-of-care (POC) devices to evaluate prothrombin time for monitoring oral anticoagulant therapy is unlike other laboratory methods, as it detects electrical signals produced by thrombin activity to derive the international normalized ratio (INR).

Scientists at Yonsei University College of Medicine (Seoul, Korea) collected 91 venous blood samples submitted for fibrinogen testing to the clinical laboratory. Platelet-poor plasma was obtained by centrifugation. The fibrinogen level was measured using Fibrinogen-C XL reagent (Instrumentation Laboratory; Milan, Italy) via Clauss method using ACL TOP (Beckman Coulter; Fullerton, CA, USA). Samples were selected after fibrinogen testing according to the fibrinogen level. PT INR was measured by both the laboratory method and CoaguChek XS (Roche Diagnostics; Mannheim, Germany).

The samples were stratified into low, mid, and high fibrinogen groups by fibrinogen levels of <130 mg/dL, 130–450 mg/dL, and >450 mg/dL, respectively. The mean INR difference of the low fibrinogen group was significantly different from that of the mid or high fibrinogen group. In the low fibrinogen group, CoaguChek XS INR showed a negative bias compared with the laboratory INR, while the mid and high fibrinogen groups had positive bias.

The authors concluded that that patient selection according to fibrinogen status should precede the implementation of POC testing using CoaguChek XS. Also, periodic comparisons between CoaguChek XS and laboratory INR results should be continued during the use of CoaguChek XS. The study was published on January 31, 2015, in the Journal of Clinical Laboratory Analysis.

Related Links:

Yonsei University College of Medicine
Instrumentation Laboratory
Roche Diagnostics


New
Gold Member
Syphilis Screening Test
VDRL Antigen MR
Automated Blood Typing System
IH-500 NEXT
New
Urine Strips
11 Parameter Urine Strips
New
Nuclear Matrix Protein 22 Test
NMP22 Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.